Charlotte Harrison

3.4k total citations
186 papers, 1.7k citations indexed

About

Charlotte Harrison is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Charlotte Harrison has authored 186 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 21 papers in Physiology. Recurrent topics in Charlotte Harrison's work include Receptor Mechanisms and Signaling (16 papers), Neuropeptides and Animal Physiology (13 papers) and Computational Drug Discovery Methods (10 papers). Charlotte Harrison is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Neuropeptides and Animal Physiology (13 papers) and Computational Drug Discovery Methods (10 papers). Charlotte Harrison collaborates with scholars based in United Kingdom, United States and Japan. Charlotte Harrison's co-authors include John R. Traynor, David G. Lambert, D Smart, Mary J. Clark, Huailing Zhong, Richard R. Neubig, K. Ravi Acharya, Robert A. Hirst, David J. Rowbotham and Piet H. van der Graaf and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature reviews. Cancer.

In The Last Decade

Charlotte Harrison

171 papers receiving 1.6k citations

Peers

Charlotte Harrison

CMN

CTM

PHYSI

Mark S. Hixon United States

Coralie Di Scala France

Graham J. Moore Canada

Ping Wu China

Zhiwei Feng United States

Subramaniam Ananthan United States

Chao‐Hsiung Lin Taiwan

Henri Chahinian France

Jatin Machhi United States

Mark S. Hixon United States

Charlotte Harrison

765 ×1.0

245 ×0.6

CMN

167 ×0.5

76 ×0.4

CTM

90 ×0.7

PHYSI

Citations per year, relative to Charlotte Harrison Charlotte Harrison (= 1×) peers Mark S. Hixon

Countries citing papers authored by Charlotte Harrison

Since Specialization

Citations

This map shows the geographic impact of Charlotte Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Harrison more than expected).

Fields of papers citing papers by Charlotte Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Harrison. The network helps show where Charlotte Harrison may publish in the future.

Co-authorship network of co-authors of Charlotte Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Harrison. A scholar is included among the top collaborators of Charlotte Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Harrison. Charlotte Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harrison, Charlotte. (2025). Vertex’s opioid-free drug for acute pain wins FDA approval. Nature Biotechnology. 43(3). 287–289. 5 indexed citations

Wang, Julie B., Rachel Yehuda, Allison R. Coker, et al.. (2024). Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS ONE. 19(1). e0295926–e0295926. 14 indexed citations

Harrison, Charlotte. (2023). Shared science’s time to shine. Lab Animal. 52(8). 179–182. 3 indexed citations

Harrison, Charlotte. (2023). Primates, like humans, focus their social circle with age. Lab Animal. 52(2). 33–33. 1 indexed citations

Harrison, Charlotte & Farida Malik. (2023). P-89 From the virtual to reality: establishing a palliative care virtual ward in a hospice/community setting. Poster presentations. A43.1–A43. 1 indexed citations

Harrison, Charlotte. (2023). Hair loss treatments take aim at the immune system. Nature Biotechnology. 41(9). 1179–1181. 1 indexed citations

Lewis, Candace R., et al.. (2023). Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD. Frontiers in Psychiatry. 14. 959590–959590. 15 indexed citations

Harrison, Charlotte. (2023). It’s all about rhythm: how the circadian cycle modulates long-term immunity. Lab Animal. 52(3). 59–59. 1 indexed citations

Wang, Julie B., Jessica Lin, Allison R. Coker, et al.. (2021). Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder. Journal of Humanistic Psychology. 14 indexed citations

10.

Harrison, Charlotte. (2021). Mice on the move. Lab Animal. 50(9). 233–235. 2 indexed citations

11.

Tollitt, James, et al.. (2020). Identification of DHX9 as a cell cycle regulated nucleolar recruitment factor for CIZ1. Scientific Reports. 10(1). 18103–18103. 6 indexed citations

12.

Harrison, Charlotte. (2020). Focus shifts to antibody cocktails for COVID-19 cytokine storm. Nature Biotechnology. 38(8). 905–908. 38 indexed citations

13.

Harrison, Charlotte. (2019). Berkeley strikes back in CRISPR patent tussle. Nature Biotechnology. 37(4). 338–339. 1 indexed citations

14.

Alakeson, Vidhya, Jed Boardman, Helen Crimlisk, et al.. (2016). Debating personal health budgets. BJPsych Bulletin. 40(1). 34–37. 12 indexed citations

15.

Harrison, Charlotte. (2011). Targeting interleukin-17 via dopamine. Nature Reviews Drug Discovery. 10(4). 259–259. 1 indexed citations

16.

Harrison, Charlotte & Piet H. van der Graaf. (2005). Current methods used to investigate G protein coupled receptor oligomerisation. Journal of Pharmacological and Toxicological Methods. 54(1). 26–35. 19 indexed citations

17.

Ko, Mei‐Chuan, et al.. (2003). Studies of μ-, κ-, and δ-Opioid Receptor Density and G Protein Activation in the Cortex and Thalamus of Monkeys. Journal of Pharmacology and Experimental Therapeutics. 306(1). 179–186. 37 indexed citations

18.

Hashiba, Eiji, Charlotte Harrison, G. Calo', et al.. (2001). Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(1). 28–33. 34 indexed citations

19.

Harrison, Charlotte, D.J. Rowbotham, David K. Grandy, & David G. Lambert. (2000). Endomorphin‐1 induced desensitization and down‐regulation of the recombinant μ‐opioid receptor. British Journal of Pharmacology. 131(6). 1220–1226. 6 indexed citations

20.

Harrison, Charlotte, D Smart, & David G. Lambert. (1998). Stimulatory effects of opioids. British Journal of Anaesthesia. 81(1). 20–28. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact